November 2008 - Page 64 of 76

MondayNov 03, 2008 4:42 am

BioSphere Medical, Inc. (NASDAQ: BSMD)

BioSphere Medical, Inc. (NASDAQ: BSMD) is focused on applying their proprietary microsphere technology to medical applications through the use of embolotherapy techniques. The company’s core technologies consist of patented bio-engineered polymers and manufacturing methods, which are used to produce miniature spherical beads with uniquely beneficial properties for a variety of medical applications. For further information, visit the Company's web site at www.equityny.com.

MondayNov 03, 2008 4:42 am

Osiris Therapeutics, Inc. (NASDAQ: OSIR)

Osiris Therapeutics, Inc. (NASDAQ: OSIR), a leading stem cell therapeutic company, has their focus on developing and marketing products for the treatment of medical conditions in the inflammatory, orthopedic, and cardiovascular areas. The company’s stem cell products have major therapeutic potential because of their ability to promote tissue regeneration, regulate inflammation and prevent pathological scar formation. For further information, visit the Company's web site at www.osiris.com.

MondayNov 03, 2008 4:41 am

Oscient Pharmaceuticals Corporation (NASDAQ: OSCI)

Oscient Pharmaceuticals Corporation (NASDAQ: OSCI), a commercial-stage pharmaceutical company, is devoted to marketing two FDA-approved products in the United States: ANTARA® capsules, a cardiovascular product; and FACTIVE® tablets, a fluoroquinolone antibiotic. ANTARA is designed to treat hypercholesterolemia (high blood cholesterol) and hypertriglyceridemia (high triglycerides) in combination with diet. FACTIVE is designed to treat acute bacterial exacerbations of chronic bronchitis and pneumonia. For further information, visit the Company's web site at www.oscient.com.

MondayNov 03, 2008 4:41 am

BioSpecifics Technologies Corp. (OTC BB: BSTC)

BioSpecifics Technologies Corp. (OTC BB: BSTC), a biopharmaceutical company, has developed and licensed injectable collagenase for three clinical indications. Their development and licensing agreement with Auxilium Pharmaceuticals (Nasdaq GM: AUXL) is for clinical indications in Dupuytren’s disease, Peyronie’s disease and frozen shoulder (adhesive capsulitis). Currently, all of their efforts are focused on the future development and commercialization of injectable collagenase products. For further information, visit the Company's web site at www.biospecifics.com.

MondayNov 03, 2008 4:41 am

Orthovita, Inc. (NASDAQ: VITA)

Orthovita, Inc. (NASDAQ: VITA), a novel spine/orthopaedic surgical biomaterials company, is focused on providing progressive bone regeneration and soft tissue healing technologies. The company’s expertise lies in developing and distributing novel, high-tech, synthetic-based biomaterial products. Currently, Orthovita has several key commercial product platforms including: Vitoss Bone Graft Substitute, Vitagel Surgical Hemostat, Cortoss Synthetic Cortical Bone, and Imbibe Delivery and Disposable Systems. For further information, visit the Company's web site at www.orthovita.com.

MondayNov 03, 2008 4:40 am

BioSante Pharmaceuticals, Inc. (NASDAQ: BPAX)

BioSante Pharmaceuticals, Inc. (NASDAQ: BPAX), a specialty pharmaceutical company, is committed to developing products for female sexual health, menopause, contraception and male hypogonadism. Lead products within their produce line include LibiGel® (transdermal testosterone gel), which is in Phase III clinical development under a U.S. Food and Drug Administration (FDA) SPA (Special Protocol Assessment); and Elestrin™ (estradiol gel) which has been developed through FDA approval. For further information, visit the Company's web site at www.biosantepharma.com.

MondayNov 03, 2008 4:40 am

Origin Agritech Limited (NASDAQ: SEED)

Origin Agritech Limited (NASDAQ: SEED), a leading agricultural biotechnology company and a top player in seed industry, specializes in researching and developing, producing, selling and distributing agricultural crop seeds. The Company's major seed products are corn, rice, cotton and canola. Located in Beijing, China, the company is focused on crop improvement and utilizes biotechnology to achieve their goals. For further information, visit the company website at: www.originagritech.com.

MondayNov 03, 2008 4:39 am

Orexigen Therapeutics, Inc. (NASDAQ: OREX)

Orexigen Therapeutics, Inc. (NASDAQ: OREX), a biopharmaceutical company, has focused their efforts on the development of pharmaceutical product candidates designed to treat obesity and other central nervous system-related disorders. The company’s lead combination product candidates targeted for obesity include: Contrave®, which is in Phase 3 clinical trials; and Empatic™, which is in the later stages of Phase 2 clinical development. For further information, visit the Company's web site at www.orexigen.com.

MondayNov 03, 2008 4:39 am

Orko Silver Corp. (TSX: OK CN)

Orko Silver Corp. (TSX: OK CN) is focused on exploring and developing for silver and gold within the borders of Mexico. The Company has a large land position in Durango State, a historically prolific silver mining region located along the Sierra Madre Occidental Mountains and is involved in three main projects, La Preciosa, Santa Monica and San Juan. The company also owns a 100% interest in the La Preciosa Project and the adjacent Santa Monica Project; in addition to a 75% interest in a Joint Venture on the adjacent San Juan property. For further information, visit the Company's web site…

MondayNov 03, 2008 4:39 am

Bionovo, Inc. (NASDAQ: BNVI)

Bionovo, Inc. (NASDAQ: BNVI), a drug discovery and development company, has their focus on developing safe and effective drugs to treat unmet medical needs in women’s health and cancer. Their aim is to improve the quality of women’s health and defeat life-threatening cancers. The company has a diverse pipeline of preclinical drug candidates to address both women’s health and cancer, and have identified or begun preclinical work on several multiple drug candidates for a variety of indications. For further information, visit the Company's web site at www.bionovo.com.

Site Search

Company Search

Month: November 2008

BioSphere Medical, Inc. (NASDAQ: BSMD)

Osiris Therapeutics, Inc. (NASDAQ: OSIR)

Oscient Pharmaceuticals Corporation (NASDAQ: OSCI)

BioSpecifics Technologies Corp. (OTC BB: BSTC)

Orthovita, Inc. (NASDAQ: VITA)

BioSante Pharmaceuticals, Inc. (NASDAQ: BPAX)

Origin Agritech Limited (NASDAQ: SEED)

Orexigen Therapeutics, Inc. (NASDAQ: OREX)

Orko Silver Corp. (TSX: OK CN)

Bionovo, Inc. (NASDAQ: BNVI)

Market Basics

Newsletter Publishers

Public Companies